Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Deep cutaneous fungal infections in solid-organ transplant recipients.

Galezowski A, Delyon J, Le Cleach L, Guégan S, Ducroux E, Alanio A, Lastennet D, Moguelet P, Dadban A, Leccia MT, Le Pelletier F, Francès C, Lebbé C, Barete S; Skin and Organ Transplantation Group of the French Society of Dermatology.

J Am Acad Dermatol. 2020 Jan 10. pii: S0190-9622(20)30043-8. doi: 10.1016/j.jaad.2019.12.064. [Epub ahead of print]

PMID:
31931081
2.

Quantification of Pneumocystis jirovecii: Cross-Platform Comparison of One qPCR Assay with Leading Platforms and Six Master Mixes.

Dellière S, Gits-Muselli M, White PL, Mengoli C, Bretagne S, Alanio A.

J Fungi (Basel). 2019 Dec 26;6(1). pii: E9. doi: 10.3390/jof6010009.

3.

Correction for Cornu et al., "Evaluation of Mass Spectrometry-Based Detection of Panfungal Serum Disaccharide for Diagnosis of Invasive Fungal Infections: Results from a Collaborative Study Involving Six European Clinical Centers".

Cornu M, Sendid B, Mery A, François N, Mikulska M, Letscher-Bru V, De Carolis E, Damonti L, Titecat M, Bochud PY, Alanio A, Sanguinetti M, Viscoli C, Herbrecht R, Guerardel Y, Poulain D.

J Clin Microbiol. 2019 Dec 23;58(1). pii: e01755-19. doi: 10.1128/JCM.01755-19. Print 2019 Dec 23. No abstract available.

4.

Outbreak-Causing Fungi: Pneumocystis jirovecii.

Dellière S, Gits-Muselli M, Bretagne S, Alanio A.

Mycopathologia. 2019 Nov 28. doi: 10.1007/s11046-019-00408-w. [Epub ahead of print] Review.

PMID:
31782069
5.

The Fungal PCR Initiative's evaluation of in-house and commercial Pneumocystis jirovecii qPCR assays: Toward a standard for a diagnostics assay.

Gits-Muselli M, White PL, Mengoli C, Chen S, Crowley B, Dingemans G, Fréalle E, L Gorton R, Guiver M, Hagen F, Halliday C, Johnson G, Lagrou K, Lengerova M, Melchers WJG, Novak-Frazer L, Rautemaa-Richardson R, Scherer E, Steinmann J, Cruciani M, Barnes R, Donnelly JP, Loeffler J, Bretagne S, Alanio A.

Med Mycol. 2019 Nov 23. pii: myz115. doi: 10.1093/mmy/myz115. [Epub ahead of print]

PMID:
31758173
6.

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.

Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, Hoenigl M, Jensen HE, Lagrou K, Lewis RE, Mellinghoff SC, Mer M, Pana ZD, Seidel D, Sheppard DC, Wahba R, Akova M, Alanio A, Al-Hatmi AMS, Arikan-Akdagli S, Badali H, Ben-Ami R, Bonifaz A, Bretagne S, Castagnola E, Chayakulkeeree M, Colombo AL, Corzo-León DE, Drgona L, Groll AH, Guinea J, Heussel CP, Ibrahim AS, Kanj SS, Klimko N, Lackner M, Lamoth F, Lanternier F, Lass-Floerl C, Lee DG, Lehrnbecher T, Lmimouni BE, Mares M, Maschmeyer G, Meis JF, Meletiadis J, Morrissey CO, Nucci M, Oladele R, Pagano L, Pasqualotto A, Patel A, Racil Z, Richardson M, Roilides E, Ruhnke M, Seyedmousavi S, Sidharthan N, Singh N, Sinko J, Skiada A, Slavin M, Soman R, Spellberg B, Steinbach W, Tan BH, Ullmann AJ, Vehreschild JJ, Vehreschild MJGT, Walsh TJ, White PL, Wiederhold NP, Zaoutis T, Chakrabarti A; Mucormycosis ECMM MSG Global Guideline Writing Group.

Lancet Infect Dis. 2019 Dec;19(12):e405-e421. doi: 10.1016/S1473-3099(19)30312-3. Epub 2019 Nov 5. Review.

PMID:
31699664
7.

New Insights Into Cryptococcus Spp. Biology and Cryptococcal Meningitis.

Temfack E, Boyer-Chammard T, Lawrence D, Delliere S, Loyse A, Lanternier F, Alanio A, Lortholary O.

Curr Neurol Neurosci Rep. 2019 Oct 31;19(10):81. doi: 10.1007/s11910-019-0993-0. Review.

PMID:
31673881
8.

Time to and differential time to blood culture positivity for assessing catheter-related yeast fungaemia: A longitudinal, 7-year study in a single university hospital.

Gits-Muselli M, Villiers S, Hamane S, Berçot B, Donay JL, Denis B, Guigue N, Alanio A, Bretagne S.

Mycoses. 2020 Jan;63(1):95-103. doi: 10.1111/myc.13024. Epub 2019 Nov 3.

PMID:
31630462
9.

Correction: Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype.

Hommel B, Sturny-Leclère A, Volant S, Veluppillai N, Duchateau M, Yu CH, Hourdel V, Varet H, Matondo M, Perfect JR, Casadevall A, Dromer F, Alanio A.

PLoS Pathog. 2019 Sep 17;15(9):e1008070. doi: 10.1371/journal.ppat.1008070. eCollection 2019 Sep.

10.

Emerging mould infections: Get prepared to meet unexpected fungi in your patient.

Dellière S, Rivero-Menendez O, Gautier C, Garcia-Hermoso D, Alastruey-Izquierdo A, Alanio A.

Med Mycol. 2019 Aug 21. pii: myz074. doi: 10.1093/mmy/myz074. [Epub ahead of print] No abstract available.

PMID:
31435678
11.

Intranasal Inoculation of Cryptococcus neoformans in Mice Produces Nasal Infection with Rapid Brain Dissemination.

Coelho C, Camacho E, Salas A, Alanio A, Casadevall A.

mSphere. 2019 Aug 7;4(4). pii: e00483-19. doi: 10.1128/mSphere.00483-19.

12.

Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus.

Colley T, Sharma C, Alanio A, Kimura G, Daly L, Nakaoki T, Nishimoto Y, Bretagne S, Kizawa Y, Strong P, Rapeport G, Ito K, Meis JF, Chowdhary A.

J Antimicrob Chemother. 2019 Oct 1;74(10):2950-2958. doi: 10.1093/jac/dkz302.

13.

Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype.

Hommel B, Sturny-Leclère A, Volant S, Veluppillai N, Duchateau M, Yu CH, Hourdel V, Varet H, Matondo M, Perfect JR, Casadevall A, Dromer F, Alanio A.

PLoS Pathog. 2019 Jul 29;15(7):e1007945. doi: 10.1371/journal.ppat.1007945. eCollection 2019 Jul. Erratum in: PLoS Pathog. 2019 Sep 17;15(9):e1008070.

14.

Recent advances in managing HIV-associated cryptococcal meningitis.

Boyer-Chammard T, Temfack E, Alanio A, Jarvis JN, Harrison TS, Lortholary O.

F1000Res. 2019 May 28;8. pii: F1000 Faculty Rev-743. doi: 10.12688/f1000research.17673.1. eCollection 2019. Review.

15.

ECMM CandiReg-A ready to use platform for outbreaks and epidemiological studies.

Koehler P, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bretagne S, Klingspor L, Lagrou K, Meis JF, Rautemaa-Richardson R, Schelenz S, Hamprecht A, Koehler FC, Kurzai O, Salmanton-García J, Vehreschild JJ, Alanio A, Alastruey-Izquierdo A, Arsic Arsenijevic V, Gangneux JP, Gow NAR, Hadina S, Hamal P, Johnson E, Klimko N, Lass-Flörl C, Mares M, Özenci V, Papp T, Roilides E, Sabino R, Segal E, Talento AF, Tortorano AM, Verweij PE, Hoenigl M, Cornely OA; European Confederation of Medical Mycology (ECMM).

Mycoses. 2019 Oct;62(10):920-927. doi: 10.1111/myc.12963. Epub 2019 Aug 1.

PMID:
31271702
16.

The enigmatic role of fungal annexins: the case of Cryptococcus neoformans.

Maryam M, Fu MS, Alanio A, Camacho E, Goncalves DS, Faneuff EE, Grossman NT, Casadevall A, Coelho C.

Microbiology. 2019 Aug;165(8):852-862. doi: 10.1099/mic.0.000815. Epub 2019 May 29.

PMID:
31140968
17.

Emerging mould infections: Get prepared to meet unexpected fungi in your patient.

Dellière S, Rivero-Menendez O, Gautier C, Garcia-Hermoso D, Alastrey-Izquierdo A, Alanio A.

Med Mycol. 2019 May 21. pii: myz039. doi: 10.1093/mmy/myz039. [Epub ahead of print]

PMID:
31111906
18.

Why are so many cases of invasive aspergillosis missed?

Danion F, Rouzaud C, Duréault A, Poirée S, Bougnoux ME, Alanio A, Lanternier F, Lortholary O.

Med Mycol. 2019 Apr 1;57(Supplement_2):S94-S103. doi: 10.1093/mmy/myy081. Review.

PMID:
30816963
19.

Evaluation of Mass Spectrometry-Based Detection of Panfungal Serum Disaccharide for Diagnosis of Invasive Fungal Infections: Results from a Collaborative Study Involving Six European Clinical Centers.

Cornu M, Sendid B, Mery A, François N, Mikulska M, Letscher-Bru V, De Carolis E, Damonti L, Titecat M, Bochud PY, Alanio A, Sanguinetti M, Viscoli C, Herbrecht R, Guerardel Y, Poulain D.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e01867-18. doi: 10.1128/JCM.01867-18. Print 2019 May. Erratum in: J Clin Microbiol. 2019 Dec 23;58(1):.

20.

Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology.

Koehler P, Mellinghoff SC, Lagrou K, Alanio A, Arenz D, Hoenigl M, Koehler FC, Lass-Flörl C, Meis JF, Richardson M, Cornely OA.

J Antimicrob Chemother. 2019 Jun 1;74(6):1704-1712. doi: 10.1093/jac/dkz051.

PMID:
30770712
21.

Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.

Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN.

Trials. 2019 Jan 14;20(1):48. doi: 10.1186/s13063-018-3155-9.

22.

Corrigendum: Continuous Decline of Toxoplasma gondii Seroprevalence in Hospital: A 1997-2014 Longitudinal Study in Paris, France.

Guigue N, Léon L, Hamane S, Gits-Muselli M, Le Strat Y, Alanio A, Bretagne S.

Front Microbiol. 2018 Nov 27;9:2814. doi: 10.3389/fmicb.2018.02814. eCollection 2018.

23.

Outcome and potentially modifiable risk factors for candidemia in critically ill burns patients: A matched cohort study.

Dudoignon E, Alanio A, Anstey J, Depret F, Coutrot M, Fratani A, Jully M, Cupaciu A, Chaussard M, Oueslati H, Ferry A, Benyamina M, de Tymowski C, Boccara D, Serror K, Chaouat M, Mimoun M, Lafaurie M, Denis B, Gits-Muselli M, Bretagne S, Mebazaa A, Legrand M, Soussi S; PRONOBURN group.

Mycoses. 2019 Mar;62(3):237-246. doi: 10.1111/myc.12872. Epub 2018 Dec 18.

PMID:
30478963
24.

AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.

Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN.

Trials. 2018 Nov 23;19(1):649. doi: 10.1186/s13063-018-3026-4. Erratum in: Trials. 2019 Jan 14;20(1):48.

25.

Reactivation of dormant/latent fungal infection.

Brunet K, Alanio A, Lortholary O, Rammaert B.

J Infect. 2018 Dec;77(6):463-468. doi: 10.1016/j.jinf.2018.06.016. Epub 2018 Jul 6. Review.

PMID:
30417827
26.

Primary antifungal prophylaxis with micafungin after allogeneic hematopoietic stem cell transplantation: a monocentric prospective study.

Xhaard A, Porcher R, Bergeron A, Alanio A, Touratier S, Bretagne S, de Margerie-Mellon C, Sicre de Fontbrune F, Itzykson R, Coman T, Robin M, Cabannes-Hamy A, Socié G, Peffault de Latour R.

Ann Hematol. 2019 Apr;98(4):1033-1035. doi: 10.1007/s00277-018-3530-3. Epub 2018 Oct 23. No abstract available.

PMID:
30353389
27.

Continuous Decline of Toxoplasma gondii Seroprevalence in Hospital: A 1997-2014 Longitudinal Study in Paris, France.

Guigue N, Léon L, Hamane S, Gits-Muselli M, Le Strat Y, Alanio A, Bretagne S.

Front Microbiol. 2018 Oct 5;9:2369. doi: 10.3389/fmicb.2018.02369. eCollection 2018. Erratum in: Front Microbiol. 2018 Nov 27;9:2814.

28.

Recent advances in the understanding and management of mucormycosis.

Pilmis B, Alanio A, Lortholary O, Lanternier F.

F1000Res. 2018 Sep 7;7. pii: F1000 Faculty Rev-1429. doi: 10.12688/f1000research.15081.1. eCollection 2018. Review.

29.

Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together.

Hoenigl M, Gangneux JP, Segal E, Alanio A, Chakrabarti A, Chen SC, Govender N, Hagen F, Klimko N, Meis JF, Pasqualotto AC, Seidel D, Walsh TJ, Lagrou K, Lass-Flörl C, Cornely OA; European Confederation of Medical Mycology (ECMM).

Mycoses. 2018 Nov;61(11):885-894. doi: 10.1111/myc.12836. Epub 2018 Aug 28.

PMID:
30086186
30.

Failure of voriconazole therapy due to acquired azole resistance in Aspergillus fumigatus in a kidney transplant recipient with chronic necrotizing aspergillosis.

Pilmis B, Garcia-Hermoso D, Alanio A, Catherinot E, Scemla A, Jullien V, Bretagne S, Lortholary O.

Am J Transplant. 2018 Sep;18(9):2352-2355. doi: 10.1111/ajt.14940. Epub 2018 Jul 12.

31.

Titan cells formation in Cryptococcus neoformans is finely tuned by environmental conditions and modulated by positive and negative genetic regulators.

Hommel B, Mukaremera L, Cordero RJB, Coelho C, Desjardins CA, Sturny-Leclère A, Janbon G, Perfect JR, Fraser JA, Casadevall A, Cuomo CA, Dromer F, Nielsen K, Alanio A.

PLoS Pathog. 2018 May 18;14(5):e1006982. doi: 10.1371/journal.ppat.1006982. eCollection 2018 May.

32.

Mechanisms of Cryptococcus neoformans-Mediated Host Damage.

Casadevall A, Coelho C, Alanio A.

Front Immunol. 2018 Apr 30;9:855. doi: 10.3389/fimmu.2018.00855. eCollection 2018. Review.

33.

Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.

Chammard TB, Temfack E, Lortholary O, Alanio A.

Mem Inst Oswaldo Cruz. 2018;113(7):e180050. doi: 10.1590/0074-02760180050. Epub 2018 May 7. Review.

34.

Outbreak of Invasive Wound Mucormycosis in a Burn Unit Due to Multiple Strains of Mucor circinelloides f. circinelloides Resolved by Whole-Genome Sequencing.

Garcia-Hermoso D, Criscuolo A, Lee SC, Legrand M, Chaouat M, Denis B, Lafaurie M, Rouveau M, Soler C, Schaal JV, Mimoun M, Mebazaa A, Heitman J, Dromer F, Brisse S, Bretagne S, Alanio A.

mBio. 2018 Apr 24;9(2). pii: e00573-18. doi: 10.1128/mBio.00573-18.

35.

Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.

Salzer HJF, Schäfer G, Hoenigl M, Günther G, Hoffmann C, Kalsdorf B, Alanio A, Lange C.

Respiration. 2018;96(1):52-65. doi: 10.1159/000487713. Epub 2018 Apr 10. Review.

36.

In Vitro and In Vivo Efficacy of a Novel and Long-Acting Fungicidal Azole, PC1244, on Aspergillus fumigatus Infection.

Colley T, Sehra G, Chowdhary A, Alanio A, Kelly SL, Kizawa Y, Armstrong-James D, Fisher MC, Warrilow AGS, Parker JE, Kelly DE, Kimura G, Nishimoto Y, Sunose M, Onions S, Crepin D, Lagasse F, Crittall M, Shannon J, McConville M, King-Underwood J, Naylor A, Bretagne S, Murray J, Ito K, Strong P, Rapeport G.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e01941-17. doi: 10.1128/AAC.01941-17. Print 2018 May.

37.

Circulating Aspergillus fumigatus DNA Is Quantitatively Correlated to Galactomannan in Serum.

Alanio A, Menotti J, Gits-Muselli M, Hamane S, Denis B, Rafoux E, Peffault de la Tour R, Touratier S, Bergeron A, Guigue N, Bretagne S.

Front Microbiol. 2017 Oct 31;8:2040. doi: 10.3389/fmicb.2017.02040. eCollection 2017.

38.

A cell impedance-based real-time in vitro assay to assess the toxicity of amphotericin B formulations.

Menotti J, Alanio A, Sturny-Leclère A, Vitry S, Sauvage F, Barratt G, Bretagne S.

Toxicol Appl Pharmacol. 2017 Nov 1;334:18-23. doi: 10.1016/j.taap.2017.08.017. Epub 2017 Sep 1.

PMID:
28865757
39.

[Fungal sinusitis].

Lafont E, Aguilar C, Vironneau P, Kania R, Alanio A, Poirée S, Lortholary O, Lanternier F.

Rev Mal Respir. 2017 Jun;34(6):672-692. doi: 10.1016/j.rmr.2016.09.004. Epub 2017 Jul 10. Review. French.

PMID:
28705685
40.

Diversity of Pneumocystis jirovecii Across Europe: A Multicentre Observational Study.

Alanio A, Gits-Muselli M, Guigue N, Desnos-Ollivier M, Calderon EJ, Di Cave D, Dupont D, Hamprecht A, Hauser PM, Helweg-Larsen J, Kicia M, Lagrou K, Lengerova M, Matos O, Melchers WJG, Morio F, Nevez G, Totet A, White LP, Bretagne S.

EBioMedicine. 2017 Aug;22:155-163. doi: 10.1016/j.ebiom.2017.06.027. Epub 2017 Jun 29.

41.

Tracing Genetic Exchange and Biogeography of Cryptococcus neoformans var. grubii at the Global Population Level.

Rhodes J, Desjardins CA, Sykes SM, Beale MA, Vanhove M, Sakthikumar S, Chen Y, Gujja S, Saif S, Chowdhary A, Lawson DJ, Ponzio V, Colombo AL, Meyer W, Engelthaler DM, Hagen F, Illnait-Zaragozi MT, Alanio A, Vreulink JM, Heitman J, Perfect JR, Litvintseva AP, Bicanic T, Harrison TS, Fisher MC, Cuomo CA.

Genetics. 2017 Sep;207(1):327-346. doi: 10.1534/genetics.117.203836. Epub 2017 Jul 5.

42.

Pneumocystis jirovecii detection in asymptomatic patients: what does its natural history tell us?

Alanio A, Bretagne S.

F1000Res. 2017 May 23;6:739. doi: 10.12688/f1000research.10619.1. eCollection 2017. Review.

43.

Fungal infections in patients treated with ibrutinib: two unusual cases of invasive aspergillosis and cryptococcal meningoencephalitis.

Baron M, Zini JM, Challan Belval T, Vignon M, Denis B, Alanio A, Malphettes M.

Leuk Lymphoma. 2017 Dec;58(12):2981-2982. doi: 10.1080/10428194.2017.1320710. Epub 2017 May 30. No abstract available.

PMID:
28554246
44.

Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?

Alanio A, Desnos-Ollivier M, Garcia-Hermoso D, Bretagne S.

Clin Microbiol Rev. 2017 Jul;30(3):671-707. doi: 10.1128/CMR.00043-16. Review.

45.

Molecular Demonstration of a Pneumocystis Outbreak in Stem Cell Transplant Patients: Evidence for Transmission in the Daycare Center.

Robin C, Alanio A, Gits-Muselli M, la Martire G, Schlemmer F, Botterel F, Angebault C, Leclerc M, Beckerich F, Redjoul R, Pautas C, Toma A, Maury S, Bretagne S, Cordonnier C.

Front Microbiol. 2017 Apr 24;8:700. doi: 10.3389/fmicb.2017.00700. eCollection 2017.

46.

Challenges in microbiological diagnosis of invasive Aspergillus infections.

Alanio A, Bretagne S.

F1000Res. 2017 Feb 17;6. pii: F1000 Faculty Rev-157. doi: 10.12688/f1000research.10216.1. eCollection 2017. Review.

47.

In Vitro and In Vivo Antifungal Profile of a Novel and Long-Acting Inhaled Azole, PC945, on Aspergillus fumigatus Infection.

Colley T, Alanio A, Kelly SL, Sehra G, Kizawa Y, Warrilow AGS, Parker JE, Kelly DE, Kimura G, Anderson-Dring L, Nakaoki T, Sunose M, Onions S, Crepin D, Lagasse F, Crittall M, Shannon J, Cooke M, Bretagne S, King-Underwood J, Murray J, Ito K, Strong P, Rapeport G.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02280-16. doi: 10.1128/AAC.02280-16. Print 2017 May.

48.

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response.

Cordonnier C, Alanio A, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Hauser PM, Lagrou K, Melchers WJ, Helweg-Larsen J, Matos O, Bretagne S, Maertens J; Fifth European Conference on Infections in Leukemia (ECIL-5; a joint venture of The European Group for Blood and Marrow Transplantation (EBMT), The European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and The European LeukemiaNet (ELN).

J Antimicrob Chemother. 2017 Apr 1;72(4):1266-1268. doi: 10.1093/jac/dkw580. No abstract available.

PMID:
28122911
49.

Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance.

Dellière S, Healey K, Gits-Muselli M, Carrara B, Barbaro A, Guigue N, Lecefel C, Touratier S, Desnos-Ollivier M, Perlin DS, Bretagne S, Alanio A.

Front Microbiol. 2016 Dec 23;7:2038. doi: 10.3389/fmicb.2016.02038. eCollection 2016.

50.

Detection of Circulating Mucorales DNA in Critically Ill Burn Patients: Preliminary Report of a Screening Strategy for Early Diagnosis and Treatment.

Legrand M, Gits-Muselli M, Boutin L, Garcia-Hermoso D, Maurel V, Soussi S, Benyamina M, Ferry A, Chaussard M, Hamane S, Denis B, Touratier S, Guigue N, Fréalle E, Jeanne M, Shaal JV, Soler C, Mimoun M, Chaouat M, Lafaurie M, Mebazaa A, Bretagne S, Alanio A.

Clin Infect Dis. 2016 Nov 15;63(10):1312-1317. Epub 2016 Aug 17.

PMID:
27535951

Supplemental Content

Loading ...
Support Center